tm
Seeing Is Believing
tm
Seeing Is Believing
SONN is currently covered by 2 analysts with an average price target of $247.45. This is a potential upside of $244.47 (8203.69%) from yesterday's end of day stock price of $2.98.
Sonnet Biotherapeutics Holdings's activity chart (see below) currently has 2 price targets and 11 ratings on display. The stock rating distribution of SONN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 20 days.
Highest price target for SONN is $30, Lowest price target is $30, average price target is $247.45.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 23-Aug-2024. First documented stock forecast 16-Dec-2021.
Currently out of the existing stock ratings of SONN, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$30
$27.02 (906.71%)
$30
3 months 1 days ago
(23-Aug-2024)
1/3 (33.33%)
$29.25 (3900.00%)
40
Buy
1 years 3 months 1 days ago
(23-Aug-2023)
0/1 (0%)
$459.69 (294.09%)
What is SONN (Sonnet Biotherapeutics Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on SONN (Sonnet Biotherapeutics Holdings) with a proven track record?
Which analyst has the current lower performing score on SONN (Sonnet Biotherapeutics Holdings) with a proven track record?
Which analyst has the most public recommendations on SONN (Sonnet Biotherapeutics Holdings)?
Which analyst is the currently most bullish on SONN (Sonnet Biotherapeutics Holdings)?
Which analyst is the currently most reserved on SONN (Sonnet Biotherapeutics Holdings)?
